NZ shares fall as F&P Healthcare loses latest patent dispute
The S&P/NZX 50 index dropped 129.08 points, or 1.5 percent, to 8,673.18. Within the index, 34 stocks fell, 11 gained and five were unchanged. Turnover was $146.3 million.
F&P Healthcare fell 4.4 percent to $13.41 on average volumes. The Munich Regional Court upheld a patent claim by rival ResMed in the two-year dispute. The breathing apparatus makers have lodged suits and countersuits across multiple jurisdictions.
Shane Solly, a portfolio at Harbour Asset Management, said F&P Healthcare is a strong business with good assets but is finding ResMed a challenging competitor. That's at a time when the stock price is also high.
"It's already trading on a relatively full valuation," Solly said.
Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.
You will also be able to comment on articles on Good Returns.